Excellent results from Sun Pharma - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Excellent results from Sun Pharma

May 2, 2000

Sun Pharma has declared excellent results for the year ended March 2000. While the turnover has increased by 35% and the net profits have grown 53%. Even if one were to take into account the turnover accruing in the current year of Rs 291 m due to the amalgamation of Gujarat Lyka, still the turnover has grown by 26% in a year when the domestic formulations have grown only by 9.2%.

(Rs m) FY1999 FY2000 Change
Sales 3,555.9 4,785.5 34.6%
Other Income 26.9 36.3 34.9%
Expenditure 2,848.7 3,717.5 30.5%
Operating Profit (EBDIT) 707.2 1,068.0 51.0%
Operating Profit Margin (%) 19.9% 22.3%  
Interest 49.3 14.4 -70.8%
Depreciation 86.6 126.9 46.5%
Profit before Tax 598.2 963.0 61.0%
Other Adjustments 12.0 -  
Tax 19.5 58.7 201.0%
Profit after Tax/(Loss) 590.7 904.3 53.1%
Net profit margin (%) 16.6% 18.9%  
Earnings per share* 38.3 19.6  

The company’s strategy of focussing on therapeutic areas such as oncology (anti–cancer), cardiology, gastro–enteritis has paid of immensely as evidenced by the growth in the topline and the improvement of operating margins. The company has written off the entire R & D expenses (Rs 15 m) incurred in the current year apart from a one time write off of Rs 40.7 m.

The stock quotes at Rs 358 currently at an earnings multiple of 18.31 times. The earnings have been taken on a fully diluted equity after a 2:1 bonus (2 shares for every one held).


Equitymaster requests your view! Post a comment on "Excellent results from Sun Pharma". Click here!

  

More Views on News

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why am I Recommending Caution? (Fast Profits Daily)

Sep 9, 2020

This is why I have changed my short-term view on the market.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Sep 22, 2020 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS